Jin Medical International Ltd.
ZJYL
$0.5852
$0.00581.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -23.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -23.67% | |||
| Cost of Revenue | 0.00% | 3.03% | |||
| Gross Profit | 0.00% | -56.42% | |||
| SG&A Expenses | 0.00% | -11.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.00% | 182.25% | |||
| Total Operating Expenses | 0.00% | -1.90% | |||
| Operating Income | 0.00% | -118.85% | |||
| Income Before Tax | 0.00% | -98.68% | |||
| Income Tax Expenses | 0.00% | -95.69% | |||
| Earnings from Continuing Operations | 0.00% | -99.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -158.89% | |||
| Net Income | 0.00% | -104.73% | |||
| EBIT | 0.00% | -118.85% | |||
| EBITDA | 0.00% | -112.78% | |||
| EPS Basic | 0.00% | -105.00% | |||
| Normalized Basic EPS | 0.00% | -106.12% | |||
| EPS Diluted | 0.00% | -105.00% | |||
| Normalized Diluted EPS | 0.00% | -106.12% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||